An Open Label, Prospective, Uncontrolled Clinical Trial to Study The Effectiveness of Homeopathic Treatment in Management of Uterine Fibroids Through Bogers Concept of Totality.
- Conditions
- Health Condition 1: D259- Leiomyoma of uterus, unspecified
- Registration Number
- CTRI/2023/06/053796
- Lead Sponsor
- EHRU HOMEOPATHIC MEDICAL COLLEGE AND HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Well diagnosed case of uterine fibroid on the basis of clinical signs and symptoms along with Ultrasonography
2.Female Patients with age group of 20-50 yrs of age
3.Those who agree to give consent to participate in the study
4.Uterine fibroid of size <5cm or 50mm.
1.Patients with complications of uterine fibroids
2.Substance abuse or dependence.
3.Patients of malignancy
4.Patients who are terminally ill, under immunosuppressive treatment or self-reported
immunocompromised state.
5.Diagnosed case of mental illness / psychiatric/ other uncontrolled/ life threatening illness affecting quality of life/any organ failure.
6.Patient unable to comply with the study protocol (including psychiatric diseases).
7.Pregnant ladies are excluded.
8.Unwilling to take part and not giving consent to join the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TERINE FIBROID SYMPTOM- HEALTH RELATED QUALITY OF LIFE QUESTIONNAIRE (UFS-QOL)Timepoint: ONE AT THE BASELINE, IN 6 MONTHS AND IN END OF STUDY( 1 YEAR)
- Secondary Outcome Measures
Name Time Method MONARCH SCALETimepoint: EVERY 4 WEEKS UPTO 1 YEAR
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.